Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
33
DGX Quote, Financials, Valuation and Earnings
Last price:
$176.00
Seasonality move
:
0.36%
Day range:
$174.59 - $176.83
52-week range:
$148.70 - $197.55
Dividend yield:
1.79%
P/E ratio:
20.66x
P/S ratio:
1.83x
P/B ratio:
2.70x
Volume:
1.6M
Avg. volume:
1.2M
1-year change:
16.2%
Market cap:
$19.6B
Revenue:
$9.9B
EPS (TTM):
$8.52
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
DGX
Quest Diagnostics, Inc.
|
$2.7B | $2.50 | 5.05% | 21.08% | $198.06 |
|
DCTH
Delcath Systems, Inc.
|
$25.3M | -$0.09 | 32.37% | -69.37% | $22.31 |
|
DHR
Danaher Corp.
|
$6B | $1.72 | 3.79% | 43.39% | $258.09 |
|
EXAS
EXACT Sciences Corp.
|
$810.6M | $0.16 | 20.69% | -84.17% | $104.56 |
|
GH
Guardant Health, Inc.
|
$235.7M | -$0.49 | 32.6% | -47.14% | $111.82 |
|
LH
Labcorp Holdings, Inc.
|
$3.6B | $4.14 | 6.94% | 131.26% | $299.71 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
DGX
Quest Diagnostics, Inc.
|
$176.06 | $198.06 | $19.6B | 20.66x | $0.80 | 1.79% | 1.83x |
|
DCTH
Delcath Systems, Inc.
|
$10.06 | $22.31 | $355.3M | 1,156.32x | $0.00 | 0% | 4.80x |
|
DHR
Danaher Corp.
|
$224.84 | $258.09 | $158.8B | 46.27x | $0.32 | 0.55% | 6.67x |
|
EXAS
EXACT Sciences Corp.
|
$101.38 | $104.56 | $19.2B | -- | $0.00 | 0% | 6.17x |
|
GH
Guardant Health, Inc.
|
$97.10 | $111.82 | $12.6B | -- | $0.00 | 0% | 13.35x |
|
LH
Labcorp Holdings, Inc.
|
$252.03 | $299.71 | $20.9B | 24.75x | $0.72 | 1.14% | 1.54x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
DGX
Quest Diagnostics, Inc.
|
46.79% | 0.203 | 30.05% | 0.90x |
|
DCTH
Delcath Systems, Inc.
|
0.83% | 1.825 | 0.25% | 12.82x |
|
DHR
Danaher Corp.
|
26.23% | 0.261 | 12.96% | 0.85x |
|
EXAS
EXACT Sciences Corp.
|
50.33% | 1.709 | 24.46% | 2.24x |
|
GH
Guardant Health, Inc.
|
136.47% | 1.840 | 16.98% | 2.94x |
|
LH
Labcorp Holdings, Inc.
|
42.88% | 0.863 | 27.39% | 1.10x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
DGX
Quest Diagnostics, Inc.
|
$911M | $420M | 7.41% | 14.33% | 14.92% | $419M |
|
DCTH
Delcath Systems, Inc.
|
$17.9M | -$388K | 1.56% | 1.59% | -1.89% | $4.3M |
|
DHR
Danaher Corp.
|
$3.6B | $1.3B | 5.07% | 6.87% | 20.73% | $1.4B |
|
EXAS
EXACT Sciences Corp.
|
$583.9M | $16.3M | -18.87% | -38% | 1.91% | $190M |
|
GH
Guardant Health, Inc.
|
$171.6M | -$99M | -36.05% | -8518.58% | -37.33% | -$45.8M |
|
LH
Labcorp Holdings, Inc.
|
$955.6M | $403.2M | 5.61% | 10.25% | 11.32% | $280.5M |
Quest Diagnostics, Inc. vs. Competitors
-
Which has Higher Returns DGX or DCTH?
Delcath Systems, Inc. has a net margin of 9.13% compared to Quest Diagnostics, Inc.'s net margin of 4.04%. Quest Diagnostics, Inc.'s return on equity of 14.33% beat Delcath Systems, Inc.'s return on equity of 1.59%.
Company Gross Margin Earnings Per Share Invested Capital DGXQuest Diagnostics, Inc.32.35% $2.15 $13.8B DCTHDelcath Systems, Inc.87.24% $0.02 $115.8M -
What do Analysts Say About DGX or DCTH?
Quest Diagnostics, Inc. has a consensus price target of $198.06, signalling upside risk potential of 12.5%. On the other hand Delcath Systems, Inc. has an analysts' consensus of $22.31 which suggests that it could grow by 121.72%. Given that Delcath Systems, Inc. has higher upside potential than Quest Diagnostics, Inc., analysts believe Delcath Systems, Inc. is more attractive than Quest Diagnostics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DGXQuest Diagnostics, Inc.7 10 0 DCTHDelcath Systems, Inc.5 0 0 -
Is DGX or DCTH More Risky?
Quest Diagnostics, Inc. has a beta of 0.618, which suggesting that the stock is 38.214% less volatile than S&P 500. In comparison Delcath Systems, Inc. has a beta of 0.410, suggesting its less volatile than the S&P 500 by 59.033%.
-
Which is a Better Dividend Stock DGX or DCTH?
Quest Diagnostics, Inc. has a quarterly dividend of $0.80 per share corresponding to a yield of 1.79%. Delcath Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quest Diagnostics, Inc. pays 39.15% of its earnings as a dividend. Delcath Systems, Inc. pays out -- of its earnings as a dividend. Quest Diagnostics, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DGX or DCTH?
Quest Diagnostics, Inc. quarterly revenues are $2.8B, which are larger than Delcath Systems, Inc. quarterly revenues of $20.6M. Quest Diagnostics, Inc.'s net income of $257M is higher than Delcath Systems, Inc.'s net income of $830K. Notably, Quest Diagnostics, Inc.'s price-to-earnings ratio is 20.66x while Delcath Systems, Inc.'s PE ratio is 1,156.32x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quest Diagnostics, Inc. is 1.83x versus 4.80x for Delcath Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DGXQuest Diagnostics, Inc.1.83x 20.66x $2.8B $257M DCTHDelcath Systems, Inc.4.80x 1,156.32x $20.6M $830K
-
Which has Higher Returns DGX or DHR?
Danaher Corp. has a net margin of 9.13% compared to Quest Diagnostics, Inc.'s net margin of 15%. Quest Diagnostics, Inc.'s return on equity of 14.33% beat Danaher Corp.'s return on equity of 6.87%.
Company Gross Margin Earnings Per Share Invested Capital DGXQuest Diagnostics, Inc.32.35% $2.15 $13.8B DHRDanaher Corp.59.87% $1.27 $69.2B -
What do Analysts Say About DGX or DHR?
Quest Diagnostics, Inc. has a consensus price target of $198.06, signalling upside risk potential of 12.5%. On the other hand Danaher Corp. has an analysts' consensus of $258.09 which suggests that it could grow by 14.79%. Given that Danaher Corp. has higher upside potential than Quest Diagnostics, Inc., analysts believe Danaher Corp. is more attractive than Quest Diagnostics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DGXQuest Diagnostics, Inc.7 10 0 DHRDanaher Corp.18 3 0 -
Is DGX or DHR More Risky?
Quest Diagnostics, Inc. has a beta of 0.618, which suggesting that the stock is 38.214% less volatile than S&P 500. In comparison Danaher Corp. has a beta of 0.892, suggesting its less volatile than the S&P 500 by 10.801%.
-
Which is a Better Dividend Stock DGX or DHR?
Quest Diagnostics, Inc. has a quarterly dividend of $0.80 per share corresponding to a yield of 1.79%. Danaher Corp. offers a yield of 0.55% to investors and pays a quarterly dividend of $0.32 per share. Quest Diagnostics, Inc. pays 39.15% of its earnings as a dividend. Danaher Corp. pays out 20.42% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DGX or DHR?
Quest Diagnostics, Inc. quarterly revenues are $2.8B, which are smaller than Danaher Corp. quarterly revenues of $6.1B. Quest Diagnostics, Inc.'s net income of $257M is lower than Danaher Corp.'s net income of $908M. Notably, Quest Diagnostics, Inc.'s price-to-earnings ratio is 20.66x while Danaher Corp.'s PE ratio is 46.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quest Diagnostics, Inc. is 1.83x versus 6.67x for Danaher Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DGXQuest Diagnostics, Inc.1.83x 20.66x $2.8B $257M DHRDanaher Corp.6.67x 46.27x $6.1B $908M
-
Which has Higher Returns DGX or EXAS?
EXACT Sciences Corp. has a net margin of 9.13% compared to Quest Diagnostics, Inc.'s net margin of -2.3%. Quest Diagnostics, Inc.'s return on equity of 14.33% beat EXACT Sciences Corp.'s return on equity of -38%.
Company Gross Margin Earnings Per Share Invested Capital DGXQuest Diagnostics, Inc.32.35% $2.15 $13.8B EXASEXACT Sciences Corp.68.64% -$0.10 $5B -
What do Analysts Say About DGX or EXAS?
Quest Diagnostics, Inc. has a consensus price target of $198.06, signalling upside risk potential of 12.5%. On the other hand EXACT Sciences Corp. has an analysts' consensus of $104.56 which suggests that it could grow by 3.14%. Given that Quest Diagnostics, Inc. has higher upside potential than EXACT Sciences Corp., analysts believe Quest Diagnostics, Inc. is more attractive than EXACT Sciences Corp..
Company Buy Ratings Hold Ratings Sell Ratings DGXQuest Diagnostics, Inc.7 10 0 EXASEXACT Sciences Corp.3 18 0 -
Is DGX or EXAS More Risky?
Quest Diagnostics, Inc. has a beta of 0.618, which suggesting that the stock is 38.214% less volatile than S&P 500. In comparison EXACT Sciences Corp. has a beta of 1.417, suggesting its more volatile than the S&P 500 by 41.664%.
-
Which is a Better Dividend Stock DGX or EXAS?
Quest Diagnostics, Inc. has a quarterly dividend of $0.80 per share corresponding to a yield of 1.79%. EXACT Sciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quest Diagnostics, Inc. pays 39.15% of its earnings as a dividend. EXACT Sciences Corp. pays out -- of its earnings as a dividend. Quest Diagnostics, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DGX or EXAS?
Quest Diagnostics, Inc. quarterly revenues are $2.8B, which are larger than EXACT Sciences Corp. quarterly revenues of $850.7M. Quest Diagnostics, Inc.'s net income of $257M is higher than EXACT Sciences Corp.'s net income of -$19.6M. Notably, Quest Diagnostics, Inc.'s price-to-earnings ratio is 20.66x while EXACT Sciences Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quest Diagnostics, Inc. is 1.83x versus 6.17x for EXACT Sciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DGXQuest Diagnostics, Inc.1.83x 20.66x $2.8B $257M EXASEXACT Sciences Corp.6.17x -- $850.7M -$19.6M
-
Which has Higher Returns DGX or GH?
Guardant Health, Inc. has a net margin of 9.13% compared to Quest Diagnostics, Inc.'s net margin of -34.97%. Quest Diagnostics, Inc.'s return on equity of 14.33% beat Guardant Health, Inc.'s return on equity of -8518.58%.
Company Gross Margin Earnings Per Share Invested Capital DGXQuest Diagnostics, Inc.32.35% $2.15 $13.8B GHGuardant Health, Inc.64.71% -$0.74 $971.9M -
What do Analysts Say About DGX or GH?
Quest Diagnostics, Inc. has a consensus price target of $198.06, signalling upside risk potential of 12.5%. On the other hand Guardant Health, Inc. has an analysts' consensus of $111.82 which suggests that it could grow by 15.16%. Given that Guardant Health, Inc. has higher upside potential than Quest Diagnostics, Inc., analysts believe Guardant Health, Inc. is more attractive than Quest Diagnostics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DGXQuest Diagnostics, Inc.7 10 0 GHGuardant Health, Inc.17 0 0 -
Is DGX or GH More Risky?
Quest Diagnostics, Inc. has a beta of 0.618, which suggesting that the stock is 38.214% less volatile than S&P 500. In comparison Guardant Health, Inc. has a beta of 1.579, suggesting its more volatile than the S&P 500 by 57.876%.
-
Which is a Better Dividend Stock DGX or GH?
Quest Diagnostics, Inc. has a quarterly dividend of $0.80 per share corresponding to a yield of 1.79%. Guardant Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quest Diagnostics, Inc. pays 39.15% of its earnings as a dividend. Guardant Health, Inc. pays out -- of its earnings as a dividend. Quest Diagnostics, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DGX or GH?
Quest Diagnostics, Inc. quarterly revenues are $2.8B, which are larger than Guardant Health, Inc. quarterly revenues of $265.2M. Quest Diagnostics, Inc.'s net income of $257M is higher than Guardant Health, Inc.'s net income of -$92.7M. Notably, Quest Diagnostics, Inc.'s price-to-earnings ratio is 20.66x while Guardant Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quest Diagnostics, Inc. is 1.83x versus 13.35x for Guardant Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DGXQuest Diagnostics, Inc.1.83x 20.66x $2.8B $257M GHGuardant Health, Inc.13.35x -- $265.2M -$92.7M
-
Which has Higher Returns DGX or LH?
Labcorp Holdings, Inc. has a net margin of 9.13% compared to Quest Diagnostics, Inc.'s net margin of 7.34%. Quest Diagnostics, Inc.'s return on equity of 14.33% beat Labcorp Holdings, Inc.'s return on equity of 10.25%.
Company Gross Margin Earnings Per Share Invested Capital DGXQuest Diagnostics, Inc.32.35% $2.15 $13.8B LHLabcorp Holdings, Inc.26.82% $3.12 $15.2B -
What do Analysts Say About DGX or LH?
Quest Diagnostics, Inc. has a consensus price target of $198.06, signalling upside risk potential of 12.5%. On the other hand Labcorp Holdings, Inc. has an analysts' consensus of $299.71 which suggests that it could grow by 18.92%. Given that Labcorp Holdings, Inc. has higher upside potential than Quest Diagnostics, Inc., analysts believe Labcorp Holdings, Inc. is more attractive than Quest Diagnostics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DGXQuest Diagnostics, Inc.7 10 0 LHLabcorp Holdings, Inc.12 5 0 -
Is DGX or LH More Risky?
Quest Diagnostics, Inc. has a beta of 0.618, which suggesting that the stock is 38.214% less volatile than S&P 500. In comparison Labcorp Holdings, Inc. has a beta of 0.989, suggesting its less volatile than the S&P 500 by 1.121%.
-
Which is a Better Dividend Stock DGX or LH?
Quest Diagnostics, Inc. has a quarterly dividend of $0.80 per share corresponding to a yield of 1.79%. Labcorp Holdings, Inc. offers a yield of 1.14% to investors and pays a quarterly dividend of $0.72 per share. Quest Diagnostics, Inc. pays 39.15% of its earnings as a dividend. Labcorp Holdings, Inc. pays out 32.58% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DGX or LH?
Quest Diagnostics, Inc. quarterly revenues are $2.8B, which are smaller than Labcorp Holdings, Inc. quarterly revenues of $3.6B. Quest Diagnostics, Inc.'s net income of $257M is lower than Labcorp Holdings, Inc.'s net income of $261.5M. Notably, Quest Diagnostics, Inc.'s price-to-earnings ratio is 20.66x while Labcorp Holdings, Inc.'s PE ratio is 24.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quest Diagnostics, Inc. is 1.83x versus 1.54x for Labcorp Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DGXQuest Diagnostics, Inc.1.83x 20.66x $2.8B $257M LHLabcorp Holdings, Inc.1.54x 24.75x $3.6B $261.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
55
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
41
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Sell
35
SMX alert for Dec 20
SMX (Security Matters) Plc [SMX] is up 11.91% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
